Literature DB >> 29435889

Immunomodulatory effect and quantitation of a cytotoxic glycosphingolipid from Murdannia loriformis.

Weena Jiratchariyakul1, Molvibha Vongsakul2, Leena Sunthornsuk3, Primchanien Moongkarndi3, Ammararat Narintorn3, Aimon Somanabandhu3, Hikaru Okabe4, August Wilhelm Frahm5.   

Abstract

NMR signal reassignments for a cytotoxic glycosphingolipid compound, 2, β-O-D-glucopyranosyl-2-(2'-hydroxy-Z-6'-enecosamide)sphingosine, isolated from an ethanolic extract of the herb Murdannia loriformis, have been achieved by use of FAB-MS, and 1D and 2D 1H and 13C NMR. The amount of 2 in the herb juice was quantitatively determined by use of a validated HPLC method (RP-18, MeOH-H2O, UV detection at 210 nm). The immunomodulatory effect of the herb juice and of 2 was proved by means of in vitro cellular immunological assays. Compound 2 at a concentration of 13 nmol L-1 stimulated PBMC proliferation and increased the CD 3,4:CD 3,8 ratio in T lymphocytes.

Entities:  

Keywords:  Commelinaceae; Cytotoxic glycosphingolipid; Immunomodulator; Murdannia loriformis; Quantitative HPLC analysis; β-O-D-glucopyranosyl-2-(2′-hydroxy-Z-6′-enecosamide)sphingosine

Year:  2006        PMID: 29435889     DOI: 10.1007/s11418-006-0040-8

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  1 in total

1.  Sphingolipids from Conyza canadensis.

Authors:  Naveen Mukhtar; Kiran Iqbal; Itrat Anis; Abdul Malik
Journal:  Phytochemistry       Date:  2002-12       Impact factor: 4.072

  1 in total
  2 in total

1.  Evaluation of anti-inflammatory, analgesic, and antipyretic activities of the ethanol extract from Murdannia loriformis (Hassk.) Rolla Rao et Kammathy.

Authors:  Phraepakaporn Kunnaja; Somsakul Pop Wongpalee; Ampai Panthong
Journal:  Bioimpacts       Date:  2014-12-27

Review 2.  Murdannia loriformis: A Review of Ethnomedicinal Uses, Phytochemistry, Pharmacology, Contemporary Application, and Toxicology.

Authors:  Intan Soraya Che Sulaiman; Azham Mohamad; Osumanu Haruna Ahmed
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.